SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-10-067182
Filing Date
2010-03-25
Accepted
2010-03-25 16:41:53
Documents
6
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A d10ka.htm 10-K/A 62348
2 CONSENT OF PRICEWATERHOUSECOOPERS, LLP dex232.htm EX-23.2 1837
3 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULES 13A-14(A)/15D-14(A) dex311.htm EX-31.1 8691
4 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULES 13A-14(A)/15D-14(A) dex312.htm EX-31.2 8633
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER dex321.htm EX-32.1 4195
6 BIOMARIN/GENZYME LLC CONSOLIDATED FINANCIAL STATEMENTS dex991.htm EX-99.1 159718
  Complete submission text file 0001193125-10-067182.txt   246804
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-26727 | Film No.: 10704933
SIC: 2834 Pharmaceutical Preparations